Gastrointestinal Diseases
Conditions
Brief summary
TARGET-GASTRO is an observational research study to conduct a comprehensive review of outcomes for patients with the chronic gastrointestinal (GI) diseases: eosinophilic gastrointestinal disease (EGID), ulcerative colitis (UC) or Crohn's disease (CD).
Interventions
OTHERObservational
Observational
Sponsors
Target PharmaSolutions, Inc.
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Disease Cohort Inclusion Criteria: * Adult\* patients at the time of enrollment with a diagnosis or major symptom of EGIDs, UC, or CD by ICD-10 code in the EHR interface
Exclusion criteria
* Death * Manual removal (sponsor or site request) * No EHR interface encounter \> 3 years. Engaged Cohort Inclusion Criteria: * Adult\* patients diagnosed and managed for these conditions invited to participate * Ability to provide written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To characterize the natural history of disease in patients with GI disease from various etiologies | 20 Years |
| To assess safety and effectiveness of treatments | 20 Years |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate provider management practices in the treatment of patients with EGIDs, UC and CD | 20 Years |
| To evaluate longitudinal and patient reported outcomes in patients with EGIDs, UC and CD | 20 Years |
| To select and evaluate quality of care measures for patients with GI Diseases | 20 Years |
Countries
United States
Outcome results
None listed